AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer
Authors: Reichenberger, F Eickelberg, O Wyser, C Perruchoud, AP Roth, M Tamm, M
Citation: F. Reichenberger et al., Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer, SWISS MED W, 131(19-20), 2001, pp. 273-279
Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma
Authors: Gencay, M Rudiger, JJ Tamm, M Soler, M Perruchoud, AP Roth, M
Citation: M. Gencay et al., Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma, AM J R CRIT, 163(5), 2001, pp. 1097-1100
Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study
Authors: Sistek, D Tschopp, JM Schindler, C Brutsche, M Ackermann-Liebrich, U Perruchoud, AP Leuenberger, P
Citation: D. Sistek et al., Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study, EUR RESP J, 17(2), 2001, pp. 214-219
Molecular mechanisms of TGF-beta antagonism by interferon gamma and cyclosporine A in lung fibroblasts
Authors: Eickelberg, O Pansky, A Koehler, E Bihl, M Tamm, M Hildebrand, P Perruchoud, AP Kashgarian, M Roth, M
Citation: O. Eickelberg et al., Molecular mechanisms of TGF-beta antagonism by interferon gamma and cyclosporine A in lung fibroblasts, FASEB J, 15(3), 2001, pp. 797-806
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study
Authors: Schuler, M Herrmann, R De Greve, JLP Stewart, AK Gatzemeier, U Stewart, DJ Laufman, L Gralla, R Kuball, J Buhl, R Heussel, CP Kommoss, F Perruchoud, AP Shepherd, FA Fritz, MA Horowitz, JA Huber, C Rochlitz, C
Citation: M. Schuler et al., Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study, J CL ONCOL, 19(6), 2001, pp. 1750-1758
Purpose of the conference
Authors: Wanner, A Boushey, H Lee, TH Perruchoud, AP
Citation: A. Wanner et al., Purpose of the conference, AM J R CRIT, 162(4), 2000, pp. S137-S137
Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions
Authors: Diacon, AH Wyser, C Bolliger, CT Tamm, M Pless, M Perruchoud, AP Soler, M
Citation: Ah. Diacon et al., Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions, AM J R CRIT, 162(4), 2000, pp. 1445-1449
Exposure to motor vehicle traffic and allergic sensitization
Authors: Wyler, C Braun-Fahrlander, C Kunzli, N Schindler, C Ackermann-Liebrich, U Perruchoud, AP Leuenberger, P Wuthrich, B
Citation: C. Wyler et al., Exposure to motor vehicle traffic and allergic sensitization, EPIDEMIOLOG, 11(4), 2000, pp. 450-456
Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells
Authors: Papakonstantinou, E Karakiulakis, G Tamm, M Perruchoud, AP Roth, M
Citation: E. Papakonstantinou et al., Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells, AM J P-LUNG, 279(5), 2000, pp. L825-L834
Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety
Authors: Bolliger, CT Zellweger, JP Danielsson, T van Biljon, X Robidou, A Westin, A Perruchoud, AP Sawe, U
Citation: Ct. Bolliger et al., Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety, BR MED J, 321(7257), 2000, pp. 329-333
Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma
Authors: Perruchoud, AP Lundback, B Yigla, M Sykes, AP
Citation: Ap. Perruchoud et al., Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma, RESP MED, 94, 2000, pp. S35-S41
P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients
Authors: Boulay, JL Perruchoud, AP Reuter, J Bolliger, C Herrmann, R Rochlitz, C
Citation: Jl. Boulay et al., P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients, CANC GENE T, 7(9), 2000, pp. 1215-1219
Occupational exposure to inhalative irritants and methacholine responsiveness
Authors: Leuenberger, P Schindler, C Schwartz, J Ackermann-Liebrich, U Tara, D Perruchoud, AP Wuthrich, B Zellweger, JP Blaser, K Bolognini, G Bongard, JP Brandli, O Domenighetti, G Elsasser, S Grize, L Karrer, W Keller, R Kunzli, N Medici, T Schoni, MH Solari, G Tschopp, JM Villiger, B Zemp, E
Citation: P. Leuenberger et al., Occupational exposure to inhalative irritants and methacholine responsiveness, SC J WORK E, 26(2), 2000, pp. 146-152
Re-estimated equations for 5th percentiles of lung function variables
Authors: Brandli, O Schindler, C Leuenberger, P Baur, X Degens, P Kunzli, N Keller, R Perruchoud, AP
Citation: O. Brandli et al., Re-estimated equations for 5th percentiles of lung function variables, THORAX, 55(2), 2000, pp. 173-174
SAPALDIA: past, present, future
Authors: Lueunberg, P Ackermann-Liebrich, U Kunzli, N Schindler, C Perruchoud, AP
Citation: P. Lueunberg et al., SAPALDIA: past, present, future, SCHW MED WO, 130(8), 2000, pp. 291-297
Early detection of infectious exacerbations by daily home spirometry in patients with cystic fibrosis
Authors: Izbicki, G Trachsel, D Rutishauser, M Perruchoud, AP Tamm, M
Citation: G. Izbicki et al., Early detection of infectious exacerbations by daily home spirometry in patients with cystic fibrosis, SCHW MED WO, 130(39), 2000, pp. 1361-1365
Takayasu disease with predominant pulmonary involvement
Authors: Elsasser, S Soler, M Bolliger, CT Jager, K Steiger, U Perruchoud, AP
Citation: S. Elsasser et al., Takayasu disease with predominant pulmonary involvement, RESPIRATION, 67(2), 2000, pp. 213-215
Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappa B in primary human vascular smooth muscle cells - Response
Authors: Eickelberg, O Roth, M Rudiger, JJ Tamm, M Perruchoud, AP Block, LH Mussmann, R
Citation: O. Eickelberg et al., Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappa B in primary human vascular smooth muscle cells - Response, CIRCULATION, 101(18), 2000, pp. E192-E192
Supplement: Inflammation in Chronic Obstructive Pulmonary Disease - From the Fourteenth Transatlantic Airway Conference - January 1999 - Purpose of the Conference
Authors: Wanner, A Boushey, H Lee, TH Perruchoud, AP
Citation: A. Wanner et al., Supplement: Inflammation in Chronic Obstructive Pulmonary Disease - From the Fourteenth Transatlantic Airway Conference - January 1999 - Purpose of the Conference, AM J R CRIT, 160(5), 1999, pp. S1-S1
Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions
Authors: Kunzli, N Stutz, EZ Perruchoud, AP Brandli, O Tschopp, JM Bolognini, G Karrer, W Schindler, C Ackermann-Liebrich, U Leuenberger, P
Citation: N. Kunzli et al., Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions, AM J R CRIT, 160(2), 1999, pp. 427-434
Prospective evaluation of an algorithm for the functional assessment of lung resection candidates
Authors: Wyser, C Stulz, P Soler, M Tamm, M Muller-Brand, J Habicht, J Perruchoud, AP Bolliger, CT
Citation: C. Wyser et al., Prospective evaluation of an algorithm for the functional assessment of lung resection candidates, AM J R CRIT, 159(5), 1999, pp. 1450-1456
Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA Study)
Authors: Zemp, E Elsasser, S Schindler, C Kunzli, N Perruchoud, AP Domenighetti, G Medici, T Ackermann-Liebrich, U Leuenberger, P Monn, C Bolognini, G Bongard, JP Brandli, O Karrer, W Keller, R Schoni, MH Tschopp, JM Villiger, B Zellweger, JP
Citation: E. Zemp et al., Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA Study), AM J R CRIT, 159(4), 1999, pp. 1257-1266
Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta 1 and TGF-beta 3
Authors: Eickelberg, O Kohler, E Reichenberger, F Bertschin, S Woodtli, T Erne, P Perruchoud, AP Roth, M
Citation: O. Eickelberg et al., Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta 1 and TGF-beta 3, AM J P-LUNG, 20(5), 1999, pp. L814-L824
A comparison of a new transtelephonic portable spirometer with a laboratory spirometer
Authors: Izbicki, G Abboud, S Jordan, P Perruchoud, AP Bolliger, CT
Citation: G. Izbicki et al., A comparison of a new transtelephonic portable spirometer with a laboratory spirometer, EUR RESP J, 14(1), 1999, pp. 209-213
Role of current and childhood exposure to cat and atopic sensitization
Authors: Roost, HP Kunzli, N Schindler, C Jarvis, D Chinn, S Perruchoud, AP Ackermann-Liebrich, U Burney, P Wuthrich, B
Citation: Hp. Roost et al., Role of current and childhood exposure to cat and atopic sensitization, J ALLERG CL, 104(5), 1999, pp. 941-947
Risultati: 1-25 | 26-30